Menu

Aktis Oncology, Inc. AKTS

Full chart Compare
Set alert

Price alert · AKTS

All alert types
15.82 USD +0.97 (+6.53%)

At closeNov 6, 2026, 4:01 PM EST

15.82 0.00 0.00%

After hours · Nov 6, 4:01 PM ET

14.83 Day range 15.97
14.59 52-week range 32.23
YTD
-29.37%
1 year
-29.37%

Revenue & Expenses

Other Income → Expenses: $10.95MExpenses → Selling, General & Admin: $13.73MExpenses → Research & Development: $67.45MGross Profit → Expenses: $6.50MRevenue → Gross Profit: $6.50MNet Loss → Expenses: $63.73MOther Income$10.95MGross Profit$6.50MNet Loss$63.73MExpenses$81.18MSelling, General & Admin$13.73MResearch & Development$67.45MRevenue$6.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AKTS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
6.50M1.49M015.35M6.62M
6.50M1.49M0-4.14M-4.03M
-74.68M-52.05M-34.79M-60.55M-41.39M
-63.73M-43.98M-28.64M-59.03M-44.16M
-78.34-62.46-12.24-1.09-1.02
AKTS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
38.93M38.31M30.66M80.48M88.32M
264.88M326.18M122.36M161.34M124.99M
77.63M80.58M18.61M57.91M7.58M
11.55M12.01M13.40M44.85M472.00K
-146.15M-87.80M-46.31M103.43M117.41M
AKTS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
-64.13M14.76M-30.00M-45.20M-29.36M
65.96M-190.40M-68.83M-34.94M-12.49M
-1.21M183.28M072.30M85.77M
-9.58M-2.86M-3.71M-27.36M-12.44M
625.00K7.65M-98.83M-7.84M43.91M